What is Anjali Chandela's NPI number?

Anjali Chandela's National Provider Identifier (NPI) is 1982652269, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Anjali Chandela's specialty?

Anjali Chandela is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Anjali Chandela located?

Anjali Chandela's practice location on file with NPPES is 14 Pidgeon Hill Dr, Sterling, VA 20165-6155.

What is Anjali Chandela's phone number?

The practice phone number listed in the NPPES registry for Anjali Chandela is (703) 450-5959.

Does Anjali Chandela accept Medicare?

Anjali Chandela is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Anjali Chandela's NPI active?

Yes — Anjali Chandela's NPI (1982652269) is active in the NPPES registry as of the last update on 2010-09-01.

IndividualActiveAccepts Medicare

Anjali Chandela, M.D.

NPI 1982652269 · Dermatology Physician · Sterling, VA

Anjali Chandela, M.D. is a Dermatology Physician provider in Sterling, VA (NPI 1982652269).

Provider details

NPI number: 1982652269
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Female
Sole proprietor: No
License: 230491 (NY)

Practice location

14 Pidgeon Hill Dr

Suite 340

Sterling, VA 20165-6155

Phone: (703) 450-5959

Street-level locationGet directions

More VA providers

Mailing address

14 Pidgeon Hill Dr

Sterling, VA 20165-6155

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 0101247349 (VA)
Allopathic & Osteopathic Physicians
Dermatology Physician207N00000XLicense 230491 (NY)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(74/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,336 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	478	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	315	$88
Destruction of Precancer Skin Growth, 1 Growth17000	213	$53
Biopsy of Related Skin Growth, First Growth11102	103	$90
Destruction of Skin Growth, 1-14 Growths17110	79	$109
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	41	31
Clobetasol Propionate	22	11
Metronidazole	22	—
Betamethasone Dipropionate	20	14
Adalimumabbrand: Humira(cf) Pen	14	—
Tretinoin	14	—
Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented	14	—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,556 across 65 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-05-05
Last updated: 2010-09-01

Frequently asked questions

What is Anjali Chandela's NPI number?: Anjali Chandela's National Provider Identifier (NPI) is 1982652269, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Anjali Chandela's specialty?: Anjali Chandela is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Anjali Chandela located?: Anjali Chandela's practice location on file with NPPES is 14 Pidgeon Hill Dr, Sterling, VA 20165-6155.
What is Anjali Chandela's phone number?: The practice phone number listed in the NPPES registry for Anjali Chandela is (703) 450-5959.
Does Anjali Chandela accept Medicare?: Anjali Chandela is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Anjali Chandela's NPI active?: Yes — Anjali Chandela's NPI (1982652269) is active in the NPPES registry as of the last update on 2010-09-01.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	478	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	315	$88
Destruction of Precancer Skin Growth, 1 Growth17000	213	$53
Biopsy of Related Skin Growth, First Growth11102	103	$90
Destruction of Skin Growth, 1-14 Growths17110	79	$109
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 8 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Triamcinolone Acetonide	41	31
Clobetasol Propionate	22	11
Metronidazole	22	—
Betamethasone Dipropionate	20	14
Adalimumabbrand: Humira(cf) Pen	14	—
Tretinoin	14	—
Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented	14	—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$1,556 across 65 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments